Inhibition of JAK1 sensitizes human head and neck cancer cells to cetuximab

被引：0
|
作者：
Bonner, J. A. [1 ]
Trummell, H. [2 ]
Yang, E. [3 ]
机构：
[1] Univ Alabama Birmingham, Radiat Oncol, Birmingham Hosp, Birmingham, AL USA
[2] Univ Alabama Birmingham, Birmingham, AL USA
[3] Univ Alabama Birmingham, Birmingham Hosp, Birmingham, AL USA
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
315P
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Should Cetuximab Replace Cisplatin in Head and Neck Cancer?
    Rowan, Karen
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (02) : 74 - +
  • [42] YAP1 is a potential biomarker for cetuximab resistance in head and neck cancer
    Jerhammar, Fredrik
    Johansson, Ann-Charlotte
    Ceder, Rebecca
    Welander, Jenny
    Jansson, Agneta
    Grafstrom, Roland C.
    Soderkvist, Peter
    Roberg, Karin
    ORAL ONCOLOGY, 2014, 50 (09) : 832 - 839
  • [43] Inhibition of Akt pathway restores the sensitivity to cetuximab in a head and neck squamous cancer cell line
    Rebucci, M.
    Dewitte, A.
    Peixoto, P.
    Lartigau, E.
    Lansiaux, A.
    EJC SUPPLEMENTS, 2010, 8 (05): : 127 - 127
  • [44] Targeting interleukin-1 to increase cetuximab efficacy in head and neck cancer
    Espinosa-Cotton, Madelyn
    McLaren, Ayana J.
    Koch, Adam T.
    Simons, Andrean L.
    CANCER RESEARCH, 2017, 77
  • [45] Cetuximab Augments Cytotoxicity with Poly (ADP-Ribose) Polymerase Inhibition in Head and Neck Cancer
    Nowsheen, Somaira
    Bonner, James A.
    LoBuglio, Albert F.
    Trummell, Hoa
    Whitley, Alexander C.
    Dobelbower, Michael C.
    Yang, Eddy S.
    PLOS ONE, 2011, 6 (08):
  • [46] Phosphorylation of TRIP13 at Y56 induces radiation resistance but sensitizes head and neck cancer to cetuximab
    Banerjee, Rajat
    Liu, Min
    Bellile, Emily
    Schmitd, Ligia B.
    Goto, Mitsuo
    Hutchinson, Marsha-Kay N. D.
    Singh, Priyanka
    Zhang, Shuang
    Damodaran, Dilna P., V
    Nyati, Mukesh K.
    Spector, Matthew E.
    Ward, Brent
    Wolf, Gregory
    Casper, Keith
    Mierzwa, Michelle
    D'Silva, Nisha J.
    MOLECULAR THERAPY, 2022, 30 (01) : 468 - 484
  • [47] Differences in radiation, cisplatin, and cetuximab sensitivity between subpopulations of head and neck cancer cells
    Nilsson, C.
    La Fleur, L.
    Roberg, K.
    EJC SUPPLEMENTS, 2010, 8 (05): : 107 - 107
  • [48] Cross-resistance of head and neck squamous cell cancer cells to cetuximab and radiation
    Bonner, J. A.
    Xing, C.
    Trummell, H.
    ANNALS OF ONCOLOGY, 2024, 35 : S1571 - S1571
  • [49] Treatment of Experimental Asthma by Lung Restricted Inhibition of Jak1
    Rardin, Hart
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
  • [50] JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies
    Sanchez, Gina A. Montealegre
    Reinhardt, Adam
    Ramsey, Suzanne
    Wittkowski, Helmut
    Hashkes, Philip J.
    Berkun, Yackov
    Schalm, Susanne
    Murias, Sara
    Dare, Jason A.
    Brown, Diane
    Stone, Deborah L.
    Gao, Ling
    Klausmeier, Thomas
    Foell, Dirk
    De Jesus, Adriana A.
    Chapelle, Dawn C.
    Kim, Hanna
    Dill, Samantha
    Colbert, Robert A.
    Failla, Laura
    Kost, Bahar
    O'Brien, Michelle
    Reynolds, James C.
    Folio, Les R.
    Calvo, Katherine R.
    Paul, Scott M.
    Weir, Nargues
    Brofferio, Alessandra
    Soldatos, Ariane
    Biancotto, Angelique
    Cowen, Edward W.
    Digiovanna, John J.
    Gadina, Massimo
    Lipton, Andrew J.
    Hadigan, Colleen
    Holland, Steven M.
    Fontana, Joseph
    Alawad, Ahmad S.
    Brown, Rebecca J.
    Rother, Kristina I.
    Heller, Theo
    Brooks, Kristina M.
    Kumar, Parag
    Brooks, Stephen R.
    Waldman, Meryl
    Singh, Harsharan K.
    Nickeleit, Volker
    Silk, Maria
    Prakash, Apurva
    Janes, Jonathan M.
    JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (07): : 3041 - 3052
12345